IPR
Topic 103 IP Competition
Topic 103 — IP and Competition Law
IP rights and competition law operate in fundamental tension. IP grants exclusivity to incentivise innovation; competition law prohibits exclusivity that harms market function. The Competition Act 2002 mediates this through Section 3(5) — exempting "reasonable conditions" imposed by IP holders from the anti-competitive agreement prohibition under Section 3. However, Section 4 (abuse of dominance) has NO equivalent IP exception. The Competition Commission of India (CCI) has actively investigated IP-related abuse of dominance, particularly Standard Essential Patents (SEPs) of Ericsson against Indian handset manufacturers (Intex, Micromax, iBall, Karbonn, Xiaomi, Lava), Monsanto's Bt cotton trait fees, and pharmaceutical industry practices. Critical jurisprudence: Telefonaktiebolaget LM Ericsson v. CCI (Del HC 30 March 2016) — patent law as special law prevails over Competition Act when properly invoked; CCI has jurisdiction over abuse of dominance even involving IP. Monsanto Holdings v. CCI (Del HC 20 May 2020) — CCI jurisdiction reaffirmed for IP-related abuse. Delhi HC LPA judgment (13 July 2023) consolidated. CCI Special Leave Petition (March 2024) pending before Supreme Court — fundamental jurisdictional question. The Competition (Amendment) Act 2023 introduced major reforms: settlement and commitment mechanisms (operational March 2024), Deal Value Threshold ₹2,000 crore for digital mergers, Penalty Guidelines 2024 (global turnover basis), Clause 4A proposed (IP exception expanded to Section 4). Recent watershed: Telefonaktiebolaget v. Lava (Del HC 2024:DHC:2698) — substantial SEP damages; FRAND framework. This topic walks through every aspect of IP-Competition interaction — Section 3(5) framework, Section 4 jurisdiction, SEP/FRAND framework, and strategic considerations.
1. The Competition Act Framework
A. Statutory Architecture
- Competition Act 2002 — enacted 14 January 2003.
- Replaced Monopolies and Restrictive Trade Practices (MRTP) Act 1969.
- Different from MRTP: prohibits ABUSE of dominance, not dominance per se.
- Establishes Competition Commission of India (CCI).
- National Company Law Appellate Tribunal (NCLAT) appeals.
B. Key Provisions for IP
Section | Provision | IP Relevance |
|---|---|---|
Section 3 | Anti-competitive agreements prohibited. | Section 3(5) IP exception. |
Section 3(5) | "Reasonable conditions" exception for IP. | Foundational IP-Competition interface. |
Section 4 | Abuse of dominance prohibited. | NO IP-specific exception (key issue). |
Section 19(4) | Factors for dominance assessment. | Includes market entry barriers (relevant to IP). |
Section 27 | Penalties for contravention. | Up to 10% turnover (now global per 2023 amendments). |
Section 60 | Non-obstante clause; overrides other laws. | Critical conflict with Patents Act. |
Section 61 | Civil court jurisdiction barred. | CCI exclusive jurisdiction. |
Section 62 | Act not in derogation of other laws. | Concurrent operation. |
2. Section 3(5) — The Foundational IP Exception
A. The Provision
Section 3(5) Competition Act 2002 "Nothing contained in this section shall restrict— (i) the right of any person to restrain any infringement of, or to impose reasonable conditions, as may be necessary for protecting any of his rights which have been or may be conferred upon him under— (a) the Copyright Act, 1957 (14 of 1957); (b) the Patents Act, 1970 (39 of 1970); (c) the Trade and Merchandise Marks Act, 1958 (43 of 1958) or the Trade Marks Act, 1999 (47 of 1999); (d) the Geographical Indications of Goods (Registration and Protection) Act, 1999 (48 of 1999); (e) the Designs Act, 2000 (16 of 2000); (f) the Semi-conductor Integrated Circuits Layout-Design Act, 2000 (37 of 2000); (ii) the right of any person to export goods from India to the extent to which the agreement relates exclusively to the production, supply, distribution or control of goods or provision of services for such export." |
B. The "Reasonable Conditions" Test
✅ Reasonable conditions framework — what is permissible The Section 3(5) exception applies ONLY to "reasonable conditions" — not unlimited IP protection from competition scrutiny. Reasonable conditions (within IP exception): · Field of use restrictions (geographic/product). · Quality control conditions for licensees. · Reasonable royalty obligations. · Most-favoured-licensee clauses. · Cross-licensing for compatible technology. · Trade secret protection conditions. Unreasonable conditions (NOT exempted): · Tying unrelated products/services. · Resale price maintenance beyond reasonable scope. · Excessive royalties (anti-competitive). · Exclusive grant-back clauses (overly restrictive). · Refusal to deal beyond IP scope. · Patent thickets used to exclude competition. Key case: FX Enterprise Solutions v. Hyundai Motor — CCI clarified Section 3(5) exception requires reasonableness test. |
C. Section 3(5) Application Cases
- FICCI Multiplex Association v. United Producers Distributors Forum — Section 3(5) reasoning.
- FX Enterprise Solutions v. Hyundai Motor — IPR exception applied to dealer agreements.
- Justickets v. BookMyShow — Section 3(5) and copyright/database rights.
- Automobiles case (CCI) — spare parts and IP exclusivity.
3. Section 4 — Abuse of Dominance (No IP Exception)
A. The Provision Framework
- Section 4(1) — prohibits abuse of dominant position.
- Section 4(2) — categories of abuse (unfair pricing, predatory pricing, denial of market access, etc.).
- NO IP exception (unlike Section 3).
- Section 19(4) — factors for dominance assessment.
- Section 27 — penalties for contravention.
B. The Critical Issue
✅ Why Section 4 has no IP exception Legislative design considerations: · IP rights inherently confer market power. · But mere dominance is permissible. · Only ABUSE of dominance is prohibited. · Section 4 thus tolerates IP-based dominance per se. · But abuse of that dominance triggers Section 4. Applied to IP: · Patent monopoly is permissible. · Charging royalty is permissible. · But excessive royalty (relative to FRAND) may be abuse. · Discriminatory licensing terms may be abuse. · Tying patented to unpatented products may be abuse. · Patent ambush (concealing SEPs in standard-setting) may be abuse. Clause 4A proposed in Competition (Amendment) Bill 2020 to add IP exception to Section 4 — NOT enacted; status uncertain. |
4. Standard Essential Patents (SEPs) and FRAND
A. SEPs Defined
- Patents essential to implement industry standards.
- Standard-setting organizations (SSOs) define standards.
- Implementers must use SEPs to comply with standard.
- SEP holders commit to FRAND terms when contributing to standard.
- FRAND = Fair, Reasonable, And Non-Discriminatory.
B. The CCI SEP Investigations — Ericsson
📖 CCI v. Ericsson Series — Foundational SEP Cases Background — Ericsson asserted SEPs for mobile telecommunications standards against Indian handset manufacturers (Intex 2014, Micromax 2014, iBall 2014, Karbonn 2014, Xiaomi 2014). CCI Allegations — Ericsson abused dominant position by: · Demanding royalty linked to handset price (not chip). · Imposing FRAND violations. · Discriminatory licensing. · Patent holdup tactics. CCI Action — Cases consolidated; investigation ongoing. Significance — Foundational SEP/FRAND cases. Established CCI jurisdiction over IP-related abuse of dominance. |
📖 Telefonaktiebolaget LM Ericsson v. CCI, (2016) W.P(C) No. 464 of 2014 (Del HC 30 March 2016) Facts — Ericsson challenged CCI jurisdiction over patent licensing disputes. Argued: Patents Act is special law for patent matters; complete code; CCI has no jurisdiction. Holding — Delhi HC: (i) CCI has jurisdiction over IP-related abuse of dominance. (ii) Patents Act and Competition Act CAN coexist. (iii) "If irreconcilable differences between Patents Act and Competition Act in so far as anti-abuse provisions are concerned, the Patents Act being special Act shall prevail." (iv) But CCI not ousted entirely. Significance — Foundational decision on IP-Competition jurisdiction. Established complementary framework. |
C. The Telefonaktiebolaget v. Lava 2024 Watershed
📖 Telefonaktiebolaget LM Ericsson v. Lava International, 2024:DHC:2698 Facts — Ericsson held SEPs for mobile telecommunications standards. Lava manufactured handsets using these standards. FRAND determination required. Holding — Delhi HC (2024:DHC:2698): (i) FRAND obligations binding. (ii) Substantial damages awarded. (iii) Seven-step novelty analysis framework for SEP litigation. (iv) Patent holder entitled to reasonable royalty. (v) Implementer must respect SEP framework. Significance — WATERSHED Indian SEP/FRAND litigation: · Substantial damages quantification. · Seven-step novelty framework. · FRAND obligation enforcement. · Mobile telecom industry implications. · Foundation for future SEP cases. |
5. Monsanto and Agricultural IP
📖 Monsanto Holdings (P) Ltd. v. CCI, May 2020 (Del HC) Facts — CCI investigated Monsanto for abuse of dominance: · Linking Bt cotton trait fees to maximum retail price (MRP) of seed packets. · Discriminatory pricing for licensees. · Restrictive sub-licensing terms. · Field of use restrictions beyond patent scope. CCI Finding — Monsanto dominant in market for "provision of Bt cotton technology in India"; abused dominance by exploitative pricing. Delhi HC — Affirmed CCI jurisdiction over IP-related abuse of dominance. Significance — Reinforced Section 4 application to IP. CCI jurisdiction reaffirmed despite IP nature of dispute. |
6. Pending Supreme Court Resolution
✅ CCI v. Ericsson + Monsanto — Supreme Court SLP March 2024 Background: · Delhi HC LPA judgment 13 July 2023 — consolidated four appeals + writ petition. · Patentees argued CCI jurisdiction ousted by Patents Act. · CCI argued public interest justifies exercise of jurisdiction. Supreme Court Notice — March 2024. · Special Leave Petition by CCI. · Fundamental jurisdictional question. · Pending decision will reshape IP-Competition framework. Key Issues: · Whether CCI has jurisdiction over patent licensing disputes. · Patents Act as "special law" vs. Competition Act non-obstante clause. · Sectoral regulator vs. competition law authority hierarchy. · Effects-based vs. form-based competition analysis. · Public interest considerations. Possible outcomes: · Affirm Delhi HC framework (CCI jurisdiction with primacy to Patents Act). · Modify framework (sectoral regulator primacy with appeal to CCI). · Reshape entire IP-Competition jurisprudence. This pending decision is most consequential current Indian competition-IP development. |
7. Competition (Amendment) Act 2023
A. Major Reforms (2023-2025)
✅ Competition (Amendment) Act 2023 — IP-relevant changes 1. SETTLEMENT AND COMMITMENT MECHANISMS (March 2024) · Apply to vertical restraints (Section 3(4)) and abuse of dominance (Section 4). · NOT cartels. · Commitments before Director General investigation report. · Settlements post-investigation. · 2025: First major settlement accepted (smart-TV OS case). 2. DEAL VALUE THRESHOLD (DVT) · ₹2,000 crore threshold for merger control. · Substantial business operations in India (SBOI). · Digital sector: 10% global users in India. · Targets killer acquisitions. 3. PENALTY GUIDELINES 2024 · Penalties on global turnover basis (overturning Excel Crop Care relevant turnover). · Significant escalation for multinationals. · Factors: gravity, duration, cooperation, corrective measures. 4. CLAUSE 4A (PROPOSED, NOT ENACTED) · "Nothing contained in section 3 or section 4 shall restrict the right of any person to restrain any infringement of, or to impose reasonable conditions, as may be necessary for protecting any of his rights which have been or may be conferred under— (a) the Copyright Act, 1957; (b) the Patents Act, 1970;..." · Would extend Section 3(5) protection to Section 4. · Status: pending; significance debated. 5. MERGER REVIEW TIMELINE · Reduced from 210 to 150 days. · Prima facie view within 30 days. |
8. International Comparison
Jurisdiction | IP-Competition Framework |
|---|---|
United States | Sherman Act + IP exception via "rule of reason" analysis; Federal Circuit + USPTO + FTC + DOJ Antitrust Division. |
European Union | Article 101-102 TFEU + IP block exemptions (Technology Transfer); EUIPO + national authorities; balance through case law. |
China | AML 2008 + 2022 amendments; SAMR enforcement; National Development and Reform Commission (NDRC) for SEP pricing. |
Japan | Antimonopoly Act + IP-specific guidelines; FTC of Japan; balance through guidelines. |
Brazil | Competition Law 12.529/2011 + IP balance; CADE enforcement. |
9. Strategic Considerations
✅ For IP rights holders — twelve points For Standard Essential Patents, anticipate FRAND and CCI scrutiny. For pharmaceutical IP, monitor abuse allegations. For licensing agreements, draft within Section 3(5) "reasonable conditions" framework. For market dominance, monitor Section 4 risk regardless of IP basis. For royalty pricing, document FRAND compliance. For tying arrangements, ensure they relate to legitimate IP scope. For litigation strategy, anticipate parallel competition + IP claims. For acquisitions, navigate Deal Value Threshold ₹2,000 crore. For Penalty Guidelines 2024, factor global turnover basis. For settlement options, leverage March 2024 mechanisms. For SEP cases, prepare seven-step novelty analysis. For complex multinational disputes, coordinate Indian and foreign frameworks. |
✅ For implementers and challengers — eight points For SEP/FRAND disputes, leverage CCI complaint mechanisms. For excessive royalty claims, document discriminatory pricing. For patent ambush concerns, raise SSO disclosure obligations. For market dominance challenges, file under Section 4. For jurisdictional defenses, leverage Patents Act as special law. For settlement, consider commitments mechanisms. For appeals, consider Delhi HC and Supreme Court avenues. For international cases, coordinate with global competition authorities. |
🎯 EXAM POINTERS — TOPIC 103
|